Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Declines in Social Support During Breast Cancer Treatment and Their Association With Exercise Capacity Reductions in Breast Cancer Survivors.

American journal of lifestyle medicine·2026
Same author

Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.

Nature medicine·2026
Same author

Cardiac remodelling and dysfunction in cancer patients receiving cardiotoxic therapies: proteomic and metabolomic profiling.

European heart journal·2026
Same author

Atrial Fibrillation Risk and Cardiovascular Events After Hematopoietic Cell Transplantation: A Prospective Cohort Study.

JACC. CardioOncology·2026
Same author

In Memoriam: Dr Eugene Braunwald, MD, MACC.

JACC. CardioOncology·2026
Same author

Tissue-Resident Memory T Cells in the Heart: An Emerging Role in Chronic Inflammation.

Immunological reviews·2026

Video Experimental Relacionado

Updated: Jun 14, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

Perspectivas futuras de la utilización de biomarcadores cardiovasculares en sobrevivientes de cáncer: una declaración

Vlad G Zaha, Salim S Hayek, Kevin M Alexander

    Circulation
    |November 10, 2021
    PubMed
    Resumen
    Este resumen es generado por máquina.

    La medicina de precisión mejora la supervivencia del cáncer, haciendo que la salud cardiovascular sea crucial. Esta declaración explora la integración de biomarcadores, imágenes y datos para la cardio-oncología personalizada, abordando las brechas actuales en la evaluación y el monitoreo del riesgo cardiovascular durante el tratamiento del cáncer.

    Palabras clave:
    Declaraciones científicas de la AHALos biomarcadoressobrevivientes de cáncerCardiologíaen el campo de la oncologíaMedicina de precisión

    Más Videos Relacionados

    Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
    10:03

    Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

    Published on: January 28, 2020

    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
    07:25

    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

    Published on: September 22, 2020

    Videos de Experimentos Relacionados

    Last Updated: Jun 14, 2026

    Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
    14:24

    Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

    Published on: January 21, 2018

    Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
    10:03

    Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

    Published on: January 28, 2020

    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
    07:25

    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

    Published on: September 22, 2020

    Área de la Ciencia:

    • Cardio-oncología
    • Descubrimiento de biomarcadores
    • Medicina de precisión

    Sus antecedentes:

    • La supervivencia del cáncer ha mejorado debido a la medicina de precisión y las inmunoterapias.
    • La salud cardiovascular es ahora un factor crítico en los resultados generales de los pacientes con cáncer.
    • Los diagnósticos de tejidos tradicionales son fundamentales para el tratamiento del cáncer, pero limitados en la cardio-oncología.

    Objetivo del estudio:

    • Explorar un enfoque sistémico para el diagnóstico de tejidos cardiovasculares en la cardio-oncología.
    • Personalizar este enfoque para diversos escenarios clínicos en el ámbito de la cardio-oncología.
    • Abordar las limitaciones y las lagunas de conocimiento en las aplicaciones actuales de biomarcadores cardiovasculares.

    Principales métodos:

    • Revisión de la literatura sobre biomarcadores cardiovasculares establecidos en pacientes con cáncer.
    • Exploración de la integración de biomarcadores circulantes, imágenes de multimodalidad, panomía y datos fisiológicos digitales.
    • Definición amplia del concepto de biomarcador para la cardioncología.

    Principales resultados:

    • Limitaciones y lagunas de conocimiento identificadas en el uso de biomarcadores cardiovasculares para la estratificación del riesgo, el monitoreo y la detección de daños.
    • Resumió la literatura actual sobre los biomarcadores cardiovasculares en la intersección del cáncer.
    • Destacó la necesidad de un enfoque sistémico y personalizado en la cardio-oncología.

    Conclusiones:

    • Se propone un enfoque sistémico que integre diversos flujos de datos para superar los desafíos en el diagnóstico cardio-oncológico.
    • La personalización de este enfoque es clave para diversas poblaciones de pacientes, tipos de cáncer y terapias.
    • Se necesitan esfuerzos concertados en el descubrimiento, la validación y la aplicación clínica de biomarcadores en el nexo cardio-oncológico.